MedTrace Logo

Effect of Agaricus Blazei (Murrill) ss. Heinemann (Sun Mushroom)

NCT00564811 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2015-05-29

No results posted yet for this study

Summary

The aim of the study was to verify the influence of Agaricus blazei (Murrill) ss. Heinemann (A. blazei) on the evolution of nutritional state and liver function in hepatitis C patients.

Conditions

  • Hepatitis C
  • Nutritional Status
  • Hepatitis, Viral, Human

Interventions

DIETARY_SUPPLEMENT

Agaricus blazei (Murrill) ss. Heinemann (sun mushroom)

Agaricus blazei powder, 10 grams/day, for 5 months

Sponsors & Collaborators

  • UPECLIN HC FM Botucatu Unesp

    lead OTHER

Principal Investigators

  • Caramori A Carlos, MD, PhD · Botucatu Medicine School - Sao Paulo State University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
24 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-03-31
Completion
2004-09-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00564811 on ClinicalTrials.gov